Search
for
Sort by
Research 961–990 of 1000+
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Immunological characteristics and histological distribution of human hair fibrous proteins studied with anti-hair keratin monoclonal antibodies HKN-2, HKN-4, and HKN-6.
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- TREATMENT OF FEMALE ANDROGENETIC ALOPECIA WITH MINOXIDIL 2%
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Sex dependent influence of a functional polymorphism in steroid 5‐α‐reductase type 2 (<i>SRD5A2</i>) on post‐traumatic stress symptoms
- Epidermal mammalian target of rapamycin complex 2 controls lipid synthesis and filaggrin processing in epidermal barrier formation
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Prostaglandin E <sub>2</sub> Receptor 2 Modulates Macrophage Activity for Cardiac Repair
- Bone morphogenetic proteins 4 and 2/7 induce osteogenic differentiation of mouse skin derived fibroblast and dermal papilla cells
- Candidate genes of SARS-CoV-2 gender susceptibility
- Anti-acne drugs in phase 1 and 2 clinical trials
- Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Contact dermatitis in reaction to 2% topical minoxidil solution
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Biallelic Variants in Lanosterol Synthase (LSS) Cause Palmoplantar Keratoderma-Congenital Alopecia Syndrome Type 2
- Synthesis, Anticancer and Molecular Docking Studies of 2-(4-chlorophenyl)-5-aryl-1,3,4-Oxadiazole Analogues
- Synthesis and Biological Evaluation of 4-(4-(Alkyl-and Phenylaminocarbonyl)benzoyl)benzoic Acid Derivatives as Non-steroidal Inhibitors of Steroid 5α-Reductase Isozymes 1 and 2
- An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism